OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study
Yuichi Inoue, Takeshi Watanabe, Shuya Takashima, et al.
Journal of Clinical Sleep Medicine (2021) Vol. 17, Iss. 5, pp. 1067-1074
Open Access | Times Cited: 6
Yuichi Inoue, Takeshi Watanabe, Shuya Takashima, et al.
Journal of Clinical Sleep Medicine (2021) Vol. 17, Iss. 5, pp. 1067-1074
Open Access | Times Cited: 6
Showing 6 citing articles:
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Assessing the Real-World, Long-Term Impact of Lemborexant on Sleep Quality in a Home-Based Clinical Study
Seiko Miyata, Kunihiro Iwamoto, Ippei Okada, et al.
Nature and Science of Sleep (2024) Vol. Volume 16, pp. 291-303
Open Access | Times Cited: 2
Seiko Miyata, Kunihiro Iwamoto, Ippei Okada, et al.
Nature and Science of Sleep (2024) Vol. Volume 16, pp. 291-303
Open Access | Times Cited: 2
Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder
Amitabh Dash, Kate Pinner, Yuichi Inoue, et al.
Sleep Medicine X (2022) Vol. 4, pp. 100044-100044
Open Access | Times Cited: 9
Amitabh Dash, Kate Pinner, Yuichi Inoue, et al.
Sleep Medicine X (2022) Vol. 4, pp. 100044-100044
Open Access | Times Cited: 9
Lemborexant levels in maternal serum, cord blood, and breast milk during pregnancy and lactation: A case report
Jumpei Saito, Mariko Ishii, Noriko Sandaiji, et al.
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Jumpei Saito, Mariko Ishii, Noriko Sandaiji, et al.
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Exposure–Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia
Bojan Lalovic, Ishani Landry, Margaret Moline, et al.
The Journal of Clinical Pharmacology (2022) Vol. 63, Iss. 4, pp. 498-511
Closed Access | Times Cited: 1
Bojan Lalovic, Ishani Landry, Margaret Moline, et al.
The Journal of Clinical Pharmacology (2022) Vol. 63, Iss. 4, pp. 498-511
Closed Access | Times Cited: 1
